Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
Said Dahbour(University of Jordan), Abdalla Awidi(University of Jordan), Dana Alhattab(King Abdullah University of Science and Technology), Emad S. Tarawneh(University of Jordan), Yacoub Bahou(University of Jordan), Murad Rasheed(University of Jordan), Ali Al‐Radaideh(Qatar University), Ammar Huneiti(Cardiff University), Fatima Jamali(University of Jordan), Mohammed Msallam(University of Jordan), Osama H. Ababneh(University of Jordan), Bayan Hourani(University of Jordan), Muawyeh Al‐Bdour(University of Jordan), Nosaiba Tawfik Al-Ryalat(University of Jordan)
Cited by 123
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial
|Urologia Internationalis|2018|109
Recent advances in using liposomes for delivery of nucleic acid-based therapeutics
|OpenNano|2023|103
Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon‐α in 1<sup>st</sup>trimester: Report of 3 cases and review of the literature
|American Journal of Hematology|2002|82